Merck
Merck drug shines at ASCO
June 4, 2014Research and Development, Sales and Marketing ASCO, Cancer, FDA, MK-3475, Merck, melanoma
Merck has shown off one of its investigative cancer drug’s impressive results in advanced head and neck cancer at ASCO …
Novartis hires Merck president to lead oncology
June 3, 2014Medical Communications, Research and Development, Sales and Marketing Bruno Strigini, MSD, Merck, Novartis, oncology
Novartis has hired Merck’s president of Europe and Canada Bruno Strigini to be its president of oncology. The role was …
BMS signs cancer deal
May 28, 2014Research and Development, Sales and Marketing ASCO, AstraZeneca, BMS, Cancer, Merck, Roche, cytomx, oncology
Bristol-Myers Squibb has partnered with CytomX Therapeutics to discover and develop new immuno-oncology candidates using the latter’s Probody Platform technology. …
Sales forecasts leave Sovaldi top and Januvia lagging
May 23, 2014Sales and Marketing Gilead, Januvia, Merck, diabetes, ep, hep C, sovaldi
Sovaldi has topped analysts’ estimates for future growth but Merck’s big-selling diabetes drug Januvia is falling by the wayside. This …
Merck sells Colorado biologics plant to KBI
May 18, 2014Manufacturing and Production KBI, Merck, manufacturing
Merck & Co has swung the axe over its M&P operations again – this time for its biologics plant in …
Merck’s vorapaxar gains long-awaited FDA approval
May 9, 2014Sales and Marketing Boehringer, FDA, Merck, lilly, vorapaxar, zontivity
Merck’s heart drug vorapaxar has finally been given the FDA go-ahead after looking dead in the water less than two …
Bayer concludes $14bn Merck consumer care takeover
May 7, 2014Sales and Marketing Bayer, Merck, OTC, consumer care, merger
Bayer has confirmed its acquisition of US firm Merck’s over-the-counter (OTC) portfolio in a deal worth $14 billion. The arrangement …
Bayer to make $14 bn move for Merck unit
May 2, 2014Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Boehringer, Merck, Novartis, Reckitt Benckiser, claritin, reuters
Bayer is in talks with Merck & Co to buy its consumer business and is willing to pay $14 billion …
Merck’s Q1 sales drop
April 30, 2014Sales and Marketing AstraZeneca, Merck, Pfizer, Q1, merger, quarter, sales
Merck & Co has released a mixed set of results for the first quarter of 2014, with drug revenue falling …
Merck gets hep C boost as competition ramps up
April 11, 2014Research and Development, Sales and Marketing Merck, daclatasvir, hep C, sovaldi
Merck has released promising data from a trial which uses two of its investigational compounds to treat patients with hepatitis …
Major new launches for 2014
March 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AbbVie, Big Pharma, Merck, Novartis, Pfizer, Roche, Sanofi, ask, johnson, lilly, top 10
AbbVie AbbVie needs a blockbuster to eventually replace its flagship Humira – and is hoping its new hepatitis C treatments …
GSK tops drug approval rates
March 7, 2014Medical Communications, Sales and Marketing FDA, GSK, J&J, JJ, Merck, Sanofi, ep, evaluate pharma, lilly, nme
GlaxoSmithKline is riding high when it comes to the approval of new medicines but US firm Lilly is falling behind. …
Merck in $100 million contraceptive settlement
February 10, 2014Sales and Marketing Merck, birth, birth control, legal, nuvaring
Merck has offered to pay $100 million to resolve thousands of legal claims brought against it for selling a birth …
Merck: ‘2014 revenues will be down’
February 7, 2014Sales and Marketing Frazier, Merck, Simponi, Singulair, isentress, q4, results
Merck is the latest pharma company to release figures suggesting 2013 was more of a struggle than it would like, …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
